FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting

Study limitation reported by the research below: “The brand name 'Balversa' was inferred for erdafitinib and is not explicitly stated in the abstract.”